(Q51980028)

English

Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma.

scientific article published in September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Hypogammaglobulinemia with a selective delayed recovery in memory B cells and an impaired isotype expression after rituximab administration as an adjuvant to autologous stem cell transplantation for non-Hodgkin lymphoma. (English)

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

14

object named as

Takao Koike

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

author name string

Mitsufumi Nishio

1

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Katsuya Fujimoto

2

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Satoshi Yamamoto

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Tomoyuki Endo

4

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Toshiya Sakai

5

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Masato Obara

6

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Kohki Kumano

7

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Koichiro Minauchi

8

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Keisuke Yamaguchi

9

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Yukari Takeda

10

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Norihiro Sato

11

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Kazuki Koizumi

12

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Masaya Mukai

13

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

publication date

1 September 2006

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

European Journal of Haematology

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

77

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

226-232

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

3

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

Peripheral blood stem cell mobilization following CHOP plus rituximab therapy combined with G-CSF in patients with B-cell non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Prolonged hypogammaglobulinemia following rituximab treatment for post transplant Epstein-Barr virus-associated lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Fludarabine, mitoxantrone and dexamethasone in the treatment of indolent B- and T-cell lymphoid malignancies in Chinese patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0609.2006.00693.X

21 January 2018

Identifiers

10.1111/J.1600-0609.2006.00693.X

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

1 reference

Europe PubMed Central

19 April 2018

http://europepmc.org/abstract/MED/16923109

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51980028&oldid=1561078573"